Sutro Biopharma Inc (STRO) stock is lower by -74.23% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives STRO stock a score of 24 out of a possible 100.
That rank is primarily influenced by a long-term technical score of 4. STRO's rank also includes a short-term technical score of 6. The fundamental score for STRO is 63. In addition to the average rating from Wall Street analysts, STRO stock has a mean target price of $30.67. This means analysts expect the stock to gain 501.29% over the next 12 months. STRO has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on STRO!